INNOVANCE Anti-Xa assay
Simplify your anticoagulant testing
Receive your quote directly from the manufacturer.
The INNOVANCE® Anti-Xa assay* is an automated chromogenic assay for the quantitative determination of the activity of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) as well as rivaroxaban, apixaban and edoxaban concentrations in citrated human plasma. The INNOVANCE Anti-Xa assay* combines a truly ready-to-use liquid reagent for heparin and DOAC testing, allowing 24/7 access to rapid, specific testing for anticoagulants. Unlike most commercially-available solutions, this assay requires no manual preparation or waiting time. INNOVANCE Anti-Xa assay has now been extended to test for edoxaban.
*Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.
